HHealth Read More New vaccine strategy targets overlooked regions of malaria parasiteAugust 8, 2026 Malaria kills more than half a million people a year, most of them young children in Africa. Two…
HHealth Read More New gum disease treatment kills harmful bacteria while saving beneficial microbesAugust 4, 2026 Researchers at Nagoya University in Japan have created an innovative treatment for periodontitis that targets and eliminates harmful…
HHealth Read More Wistar scientists develop new bispecific T cell engager to target ovarian cancerJuly 21, 2026 Wistar scientists have developed a new type of bispecific T cell engager, or BTE, that is effective against…
HHealth Read More Memory B cells reveal how nasal vaccines could stop respiratory infections earlierJuly 7, 2026 New insights into lung-resident memory B cells show why the next generation of vaccines may need to protect…
HHealth Read More WHO launches PARTNERS clinical trial for Bundibugyo virus treatmentsJuly 3, 2026 In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the…
HHealth Read More COVID-19 vaccine boosters may protect against future animal coronavirus outbreaksJuly 1, 2026 COVID-19 vaccine boosters not only protect against SARS‑CoV‑2 – the virus behind the most recent pandemic – but…
HHealth Read More Heart tissue repair drug may also help repair and regenerate damaged kidney tissuesJune 16, 2026 A drug previously developed at UCLA to help heart tissue repair itself after a heart attack might also…
HHealth Read More Study identifies genetic marker associated with severe IBDJune 16, 2026 In the largest genetic study of inflammatory bowel disease (IBD) traits to date, researchers have identified a genetic…
TTechnology Read More Researchers discover a biological barrier that limits mucosal vaccine immunityJune 4, 2026 A consistent biological barrier that stops the immune system from making the antibodies most needed to protect the…
HHealth Read More Study finds serious blood-related side effects associated with antibody-drug conjugatesJune 2, 2026 A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated…
HHealth Read More Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic SclerosisMay 14, 2026 Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus…
HHealth Read More Childhood flu infection leaves lasting immune imprintApril 17, 2026 Why the flu you caught as a child could determine your risk decades later. and what it means…